This article has Open Peer Review reports available.
The effect of activity-based financing on hospital length of stay for elderly patients suffering from heart diseases in Norway
© Yin et al.; licensee BioMed Central Ltd. 2013
Received: 3 January 2013
Accepted: 25 April 2013
Published: 7 May 2013
Whether activity-based financing of hospitals creates incentives to treat more patients and to reduce the length of each hospital stay is an empirical question that needs investigation. This paper examines how the level of the activity-based component in the financing system of Norwegian hospitals influences the average length of hospital stays for elderly patients suffering from ischemic heart diseases. During the study period, the activity-based component changed several times due to political decisions at the national level.
The repeated cross-section data were extracted from the Norwegian Patient Register in the period from 2000 to 2007, and included patients with angina pectoris, congestive heart failure, and myocardial infarction. Data were analysed with a log-linear regression model at the individual level.
The results show a significant, negative association between the level of activity-based financing and length of hospital stays for elderly patients who were suffering from ischemic heart diseases. The effect is small, but an increase of 10 percentage points in the activity-based component reduced the average length of each hospital stay by 1.28%.
In a combined financing system such as the one prevailing in Norway, hospitals appear to respond to economic incentives, but the effect of their responses on inpatient cost is relatively meagre. Our results indicate that hospitals still need to discuss guidelines for reducing hospitalisation costs and for increasing hospital activity in terms of number of patients and efficiency.
Whether the activity-based financing of hospitals provides staff with incentives to reduce the length of each hospital stay is an empirical question that needs investigation. In this paper, we analyse how the activity-based component of a hospital’s financing system influences the average length of hospital stays (LOS) for elderly patients suffering from ischemic heart diseases in Norway.
Studies that evaluate the effects of introducing prospective financing systems that are based on the DRG system in US hospitals during the 1980s indicated a significant reduction in LOS in the range of -3 to -9% [1–10]. The results of European research are divergent, but most EU studies indicate that introducing a prospective payment system ultimately engenders negative effects on LOS, such as -24% in Hungary  and -4.6% in Austria . All of the studies that are listed in this section have analysed the effects of fundamental system changes. In contrast, we concentrate our analysis on the effects of incremental changes in the activity-based component. The hospitals in many countries are likely to find our focus to be relevant, because many countries have implemented systems that combine activity-based financing in the DRG system with a component based on fixed payments.
Chalkley and Malcomson already delineated a theoretical understanding of changes in the financing system for non-profit hospitals [13, 14], and Biørn et al. adapted this theory to the Norwegian setting [15, 16]. These models often assume a trade-off between efficiency and quality in hospital production that can be shifted by various reimbursement systems. Low-powered financing systems, i.e., reimbursement systems with weak economic incentives, can give rise to serious inefficiencies in the hospital system, yet the public’s perception of the system’s healthcare services can meanwhile improve. High-powered prospective payment systems, on the other hand, increase efficiency, but can generate severe quality problems due to creaming (overtreating low-risk patients), skimping (reducing quality in various ways, such as reducing LOS), or dumping (avoiding the treatment of high-risk patients).
We have examined the level of the activity-based component over a period of 8 years, and analysed how the level correlates with LOS. To reduce the problem of intradiagnostic heterogeneity in LOS, we limit the present analysis to 3 ischemic heart diseases: angina pectoris, congestive heart failure, and myocardial infarction. We analysed our data with a log-linear regression model.
Treatment of patients with heart diseases
The patients’ data were extracted from the Norwegian Patient Register. These data include all individuals in Norway who were suffering from at least one of 3 different ischemic diagnoses at the time the data were originally collected.
Angina pectoris is temporary chest pain or a sensation of pressure on the chest that occurs when the heart muscle is deprived of oxygen. It is caused by a partially narrowed artery. Its treatment is typically determined by the stability and the severity of the symptoms. When symptoms are stable and manifest mildly or moderately, the common choice of treatment is medication and modification of risk factors (e.g., smoking). When symptoms are unstable, immediate hospitalisation is usually required so that doctors can closely monitor a more intensive drug therapy and can consider the necessity of invasive procedures, such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
Myocardial infarction is usually a medical emergency situation in which some of the heart’s blood supply is suddenly and severely reduced or cut off, causing the heart muscle (myocardium) to die because of oxygen supply deprivation. Myocardial infarction is caused by a totally blocked coronary artery, so it requires prompt intervention. In addition to drug therapy, doctors often elect to apply both PCI and CABG to patients with myocardial infarction.
Congestive heart failure is generally defined as the heart’s inability to supply sufficient blood flow to meet the body’s needs. Myocardial infarction is one of the most common causes of congestive heart failure. Treatments of congestive heart failure vary to address the various potential causes. Surgery is a valid treatment if the cause of heart failure is a narrowed or leaking heart valve or an abnormal connection between heart chambers. Blockage or severe narrowing of a coronary artery is likely to require drugs, surgery, or angioplasty. Heart transplantation may also be an option for a few otherwise healthy people who have not responded well to traditional therapy.
Both PCI and CABG treatment in Norway are centralised to specialised hospitals. PCI, which is the procedure most frequently used, is centralised to eight intervention centres. For this reason, patients, especially myocardial infarction patients who live in a catchment area with only local hospitals, may first be admitted to a local hospital and then transferred to an intervention centre outside the catchment area. In such a case, they would return to the local hospital before discharge. Since our data are hospital-based and not episode-based, the LOS for these patients might be separated into 2 or even several parts. We discuss this problem later in this paper.
The empirical analysis is based on repeated cross-sectional data from 49 public hospitals and 4 private, non-profit hospitals. Data were delivered by the Norwegian Patient Register. The Department of Health Management and Health Economics, University of Oslo applied and received permission to use these data for this research project. The data set includes the individual patient variables of age, sex, diagnoses, DRG weights, number of comorbidities, admission type (non-elective or elective), and LOS (in days). The study also complies with the international and national ethical standards described by The National Committee for Research Ethics in the Social Sciences and the Humanities and by the Regional Committees for Medical Research Ethics (REK). The approved individual data set for our empirical data analysis is strictly confidential.
Defining catchment area groups
Modelling the length of stay
where Y i is the logarithm of length of stay for admission number i, x ′ i is a vector of exogenous variables, α is unobserved individual effects, u i is an error term, and β is a vector of coefficients.
According to the literature, longer LOS is associated with older patients , females [12, 21], patients with more comorbidities , patients with a higher DRG weight , patients with non-elective admission to the hospital , and the incentives of the financing system [11–13, 23, 24]. Furthermore, other time-related factors can influence LOS, such as technology improvements, development of outpatient care and nursing homes, and patients’ preferences for short stays [23–25]. By gleaning the literature and available data, we therefore included the following explanatory variables in the empirical analysis: age, age square, gender (female = 1, male = 0), level of ABF (the activity-based component), the DRG weight, number of comorbidities, a patient admission dummy (non-elective = 1, elective = 0), 2 dummies of ischemic heart diagnosis (myocardial infarction = 0, angina pectoris = 1, congestive heart failure = 1), 2 dummies from the 3 catchment area groups (Group 1 = 1, Group 2 = 1, Group 3 = 0), and a linear time trend variable to represent the influence of technological improvements and other time-related factors. The DRG weights and the number of comorbidities were included to account for severe cases and cases of mixed severity, which can influence resource use.
We estimated OLS regression of y on x i in equation 1. In order to justify that the residuals are normally distributed, we estimated the logarithm of LOS instead of LOS itself. The coefficient β measures the effect of a change in regressor x i on E(ln(LOS)|x). In order to investigate the possible problems of heterogeneity, we also developed a pseudo-panel model  by utilising Hausman-Taylor estimation , and we describe this model and estimation in the Appendix.
Descriptive statistics of ischemic heart diseases patients, based on the individual Norwegian patient register dataset during 2000-2007
Ischemic heart diseases patients
Congestive heart failure
Length of stay
No. of Comorbidities
Congestive heart failure(%)
OLS regressions at the individual level
Congestive heart failure
No. of co morbidities
Congestive heart failure
When we estimated the 3 diagnoses separately (shown in columns 2–4), we found that increasing the activity-based component significantly reduces LOS for myocardial infarction patients. Myocardial infarction patients also have the strongest negative time trend effects among all 3 disease types. In contrast, increasing the activity-based component has no effect on the LOS of patients with congestive heart failure and/or angina pectoris.
The pseudo-panel model in the Appendix displays results that are compatible with our individual-level analysis. This model gave far less accurate estimates, however, which is the reason why we primarily present the individual level log-linear model results. Additionally, we used a linear multilevel regression model and a negative binominal regression model. The results are similar in magnitude and significance, as Table 2 indicates.
Discussion and conclusions
We have studied how the level of the activity-based component in the hospitals’ financing system influences the average length of hospital stays for elderly patients suffering from ischemic heart diseases. The results show that when the activity-based component increases by 10 percentage points, the average LOS of such elderly patients decreases by 1.28% or approximately 1.36 hours (1.28%*4.42 days*24 hours). In other words, the hospitals are responding to the economic incentive of an incremental change in the activity-based component, but the incentive’s ultimate impact on LOS is rather small.
We also found that other factors besides the activity-based component are associated with longer LOS, in particular older patients, females, higher DRG weight, more comorbidities, non-elective admission, and being diagnosed with myocardial infarction. These results are in accordance with findings from previous studies. The LOS for patients who had stayed in catchment area group 1 and catchment area group 2 were longer than the LOS for group 3, which verifies that the LOS for patients in catchment area group 3 are likely to have been divided due to the geographic location of the PCI centres. The time trend variable, which is assumed to capture the effects of technological progress, significantly reduces LOS. Myocardial infarction patients have the strongest negative time trend effects among the patient groups. The myocardial infarction patients are recovering faster in recent years due to the introduction of PCI treatment.
In the diagnosis-specific analyses, we discovered that increasing the activity-based component significantly reduces LOS for myocardial infarction patients but not for patients with congestive heart failure and angina pectoris. This discrepancy might come from some other factors that influence LOS among the latter 2 types of patients, such as standardisation of practice, interdisciplinary team dynamics, and physician leadership [28–32].
There has been much political debate regarding how to reduce hospital costs. The conventional view is that increasing the activity-based component results in a reduction in the length of patient stay and hence reduced costs. Our results indicate that a reduction in the activity-based component in the current high-powered prospective payment system in Norway has only a small impact on the reduction of LOS. Therefore, an incremental change in the activity-based component does not appear to give hospitals strong enough incentives to reduce inpatient costs considerably for this specific patient group. The small effect observed in this analysis might also have been caused by some hospitalisation regulations and instructions for the treatment of these 3 ischemic heart diseases. For instance, these patients must stay at the hospitals for a fixed amount of days to fulfil the standard treatment plans for these diseases. On the other hand, our results indicate that a higher activity-based component is still generally recommendable, because it has a positive effect on hospital activities in terms of number of patients and hospital efficiencies [13, 14, 24]. Another factor is that Norwegian physicians work on a salary basis and do not receive pay according to the number of treated patients. They might not have the right economic incentives to work directly to reduce the length of stay.
Our scope of interest in this paper has been restricted to the effect of the activity-based component on LOS for elderly patients suffering from heart diseases. One limitation of the present study is that we focus only on patients with these 3 ischemic heart diseases. Due to the treatment specialties for this patient group, the effects on LOS probably differ for other patient groups, especially for diagnoses with no prevailing treatment instructions. The other limitation of this study is that we did not account for other factors that might influence LOS while conducting our analyses, such as waiting time, supply of beds, staffing ratios, patients’ rate of recovery, hospital and physician characteristics [26, 33], and specific indicators that reflect the severity of illness for this patient group, e.g., the number of affected vessels and the ejection fraction. It would be interesting to explore how these factors impact LOS, as well. However, it is reasonable to assume that there is no correlation between these factors and the activity-based component, so we expect none of these factors to influence the activity-based component’s effect on LOS.
If the unobserved individual effects α are uncorrelated with the explanatory variables in x′ i in equation 1, we can get the consistent and unbiased estimator by simply using OLS in the repeated cross-sectional dataset. However, in reality, the unobserved individual effects are likely to be correlated with some or all of the explanatory variables, which creates the unobserved heterogeneity problem. For example, one patient might have more comorbidities than other patients due to the severity of his or her diseases, such as the number of affected vessels, ejection fraction, etc. Therefore, OLS might lead to inconsistent estimators. If we have genuine panel data, then we can easily solve this problem by using the fixed effects model or the Hausman-Taylor (HT) model  in equation 1. Unfortunately, we had access to only repeated cross-section data, so we could not follow the same individuals over time. This limitation implies that the traditional panel approach cannot be used directly in equation 1.
Deaton  suggested using the pseudo-panel technique to perform panel estimation at the aggregated level. We first had to group the individuals into pseudo-cohorts based on a fixed membership that remained the same throughout the entire period of observation. Here, we defined each cohort C for every combination of single birth year and gender. In order to make the cohort sizes fairly equal across cohort groups, we merged the oldest and youngest birth year for male and female patients separately (birth year < =1911 or > =1967 for males and birth year < =1908 or > =1958 for females). Hence, each individual patient in the data set belongs to exactly one cohort. This new data set is a pseudo-panel or a synthetic panel with repeated observations over T periods and C cohorts. It should also be noted that we reduced the number of observations from 331,046 to 847 with this cohort grouping, indicating that the estimates from the pseudo-panel method are less biased but suffer from less precision.
where are the averages of all observed ln(LOS)’s in cohort c at time period t, and similarly for the other variables in the model. is the fixed cohort effects, which is correlated with (we assume in equation 2). The dependent and the explanatory variables in equation 2 are weighted with the square root of the cohort size before estimating, because the sample cohort means should be the more reliable proxies for the population cohort means when the corresponding cohort is large . We can then estimate equation 2 with the fixed effects model, and this model gives the within estimator [26–31]. Even if the within estimator is a consistent and unbiased estimator, it suffers from 2 significant defects . First, all time-invariant variables are eliminated by the data transformation, so their coefficients cannot be estimated (for example, the coefficient of female is removed). Second, the within estimator is not fully efficient, because it ignores the variation across individuals.
Where and are vectors of time-varying variables, and and are vectors of time-invariant variables. In addition, and are 2 vectors of exogenous variables in that they do not correlate with and , while and are 2 endogenous variables that correlate with but not with . Because and correlate with , estimating equation 3 by using the random effects model does not result in consistent parameters. If we estimate equation 3 by using the fixed effects model, we are not estimating γ 1 or γ 2, because this model eliminates and .
Hausman-Taylor estimation at the cohort level
No. of comorbidities
Congestive heart failure
Moreover, when we compared log-linear regression at the individual level (Table 2) with HT estimation at the cohort level (Table 3), we revealed that the sign and the size of the explanatory variables are similar except for gender, angina pectoris, and 2 catchment area group variables (group 1 and group 2). The 4 variables now turn out to be insignificant, which reflects a trade-off between estimate accuracy and estimate bias. The results at the cohort level are less biased, but they lack the prize of precision. As one can see by looking at Table 3, the confidence intervals of the HT estimates are within the confidence intervals of the log-linear estimates, and the standard errors at the cohort level are larger than they are at the individual level. This result is normal, because the number of cohort groups is lower than the number of individual observations. Therefore, we do not analyse the data separately with 3 different diagnoses at the cohort level in order to prevent the standard errors that are largely spread out at the cohort level. Our final results are based on a log-linear regression at the individual level (Table 2), because it is more precise.
The authors are grateful for the financial support from the Foundation for Health Services Research (HELTEF). In addition, Biørn Erik and Kann Inger Cathrine provided invaluable suggestions for this study. We would also like to thank the seminar participants at the University of Oslo and Akershus University Hospital for their helpful comments and discussions. This paper was presented at the 8th European Conference on Health Economics (ECHE 2010) in Finland, the 8th World Congress on Health Economics (IHEA 2011) in Toronto, and the 32nd Nordic Health Economists’ Study Group (NHESG) meeting in Odense. The usual disclaimers apply.
- Guterman S, Dobson A: Impact of the Medicare prospective payment system for hospitals. Health Care Financing Rev. 1986, 7 (3): 97-114.Google Scholar
- Newhouse JP, Byrne DJ: Did Medicare’s Prospective Payment System cause length of stay to fall?. J Health Econ. 1988, 7 (4): 413-416. 10.1016/0167-6296(88)90023-9.View ArticlePubMedGoogle Scholar
- Freiman MP, Ellis RP, McGuire TG: Provider response to Medicare’s PPS: reductions in length of stay for psychiatric patients treated in scatter beds. Inquiry J Med Care Org, Prov Financing. 1989, 26 (2): 192-201.Google Scholar
- Frank RG, Lave JR: A comparison of hospital responses to reimbursement policies for Medicaid psychiatric patients. Rand J Econ. 1989, 20 (4): 588-600. 10.2307/2555735.View ArticlePubMedGoogle Scholar
- Gay EG, Kronenfeld JJ: “Regulation, retrenchment--the DRG experience: problems from changing reimbursement practice.,”. Soc Sci Med (1982). 1990, 31 (10): 1103-1118. 10.1016/0277-9536(90)90232-H.View ArticleGoogle Scholar
- Ellis RP, McGuire TG: Hospital response to prospective payment: moral hazard, selection, and practice-style effects. J Health Econ. 1996, 15 (3): 257-277. 10.1016/0167-6296(96)00002-1.View ArticlePubMedGoogle Scholar
- Ellis RP: Creaming, skimping and dumping: provider competition on the intensive and extensive margins. J Health Econ. 1998, 17 (5): 537-555. 10.1016/S0167-6296(97)00042-8.View ArticlePubMedGoogle Scholar
- Gilman BH: Hospital response to DRG refinements: the impact of multiple reimbursement incentives on inpatient length of stay. Health Econ. 2000, 9 (4): 277-294. 10.1002/1099-1050(200006)9:4<277::AID-HEC513>3.0.CO;2-1.View ArticlePubMedGoogle Scholar
- Norton EC, Van Houtven CH, Lindrooth RC, Normand S-LT, Dickey B: Does prospective payment reduce inpatient length of stay?. Health Econ. 2002, 11 (5): 377-387. 10.1002/hec.675.View ArticlePubMedGoogle Scholar
- Dafny LS: How Do Hospitals Respond to Price Changes?. Am Econ Rev. 2005, 95 (5): 1525-1547. 10.1257/000282805775014236.View ArticleGoogle Scholar
- Kroneman M, Nagy J: “Introducing DRG-based financing in Hungary: a study into the relationship between supply of hospital beds and use of these beds under changing institutional circumstances.,”. Health policy (Amsterdam, Netherlands). 2001, 55 (1): 19-36. 10.1016/S0168-8510(00)00118-4.View ArticleGoogle Scholar
- Theurl E, Winner H: “The impact of hospital financing on the length of stay: evidence from Austria.,”. Health policy (Amsterdam, Netherlands). 2007, 82 (3): 375-389. 10.1016/j.healthpol.2006.11.001.View ArticleGoogle Scholar
- Chalkley M, Malcomson JM: Contracting for health services when patient demand does not reflect quality. J Health Econ. 1998, 17 (1): 1-19. 10.1016/S0167-6296(97)00019-2.View ArticlePubMedGoogle Scholar
- Chalkley M: Government purchasing of health services in Handbook of Health Economics, Vol. 1A. 2000, Amsterdam: Elsevier, 847-889. 1Google Scholar
- Biørn E, Hagen TP, Iversen T, Magnussen J: The effect of activity-based financing on hospital efficiency: a panel data analysis of DEA efficiency scores 1992–2000. Health Care Manag Sci. 2003, 6 (4): 271-283. 10.1023/A:1026212820367.View ArticlePubMedGoogle Scholar
- Biørn E, Hagen TP, Iversen T, Magnussen J: How different are hospitals’ responses to a financial reform? The impact on efficiency of activity-based financing. Health Care Manag Sci. 2010, 13 (1): 1-16. 10.1007/s10729-009-9106-y.View ArticlePubMedGoogle Scholar
- Johannessen K-A, Hagen TP: “Variations in labor supply between female and male hospital physicians: results from a modern welfare state.,”. Health policy (The Employers Organization Spekter, Norway). 2012, 107 (1): 74-82.Google Scholar
- Martin S, Smith P: Explaining variations in inpatient length of stay in the National Health Service. J Health Econ. 1996, 15 (3): 279-304. 10.1016/0167-6296(96)00003-3.View ArticlePubMedGoogle Scholar
- King KM: Gender and short-term recovery from cardiac surgery. Nursing Res. 2000, 49 (1): 29-36. 10.1097/00006199-200001000-00005.View ArticleGoogle Scholar
- Jørgensen HS, Reith J, Nakayama H, Kammersgaard LP, Raaschou HO, Olsen TS: What determines good recovery in patients with the most severe strokes? The Copenhagen Stroke Study. Stroke J Cereb Circulation. 1999, 30 (10): 2008-2012. 10.1161/01.STR.30.10.2008.View ArticleGoogle Scholar
- Moloney ED, Bennett K, Silke B: Patient and disease profile of emergency medical readmissions to an Irish teaching hospital. Postgrad Med J. 2004, 80 (946): 470-474. 10.1136/pgmj.2003.017624.View ArticlePubMedPubMed CentralGoogle Scholar
- Kuo Y-F, Goodwin JS: Effect of hospitalists on length of stay in the medicare population: variation according to hospital and patient characteristics. J Am Geriatrics Soc. 2010, 58 (9): 1649-1657. 10.1111/j.1532-5415.2010.03007.x.View ArticleGoogle Scholar
- Sloan FA, Valvona J: Why has hospital length of stay declined? An evaluation of alternative theories. Soc Sci Med. 1986, 22 (1): 63-73. 10.1016/0277-9536(86)90309-6.View ArticlePubMedGoogle Scholar
- Clarke A: Why are we trying to reduce length of stay? Evaluation of the costs and benefits of reducing time in hospital must start from the objectives that govern change. QHC. 1996, 5 (3): 172-179.PubMedPubMed CentralGoogle Scholar
- Simpson S, Packer C, Stevens A, Raftery J: Predicting the impact of new health technologies on average length of stay: development of a prediction framework. Int J Technol Assess Health Care. 2005, 21 (4): 487-491.View ArticlePubMedGoogle Scholar
- Deaton A: “Panel data from time series of cross-sections,”. J Econ. 1985, 109-126.Google Scholar
- Hausman JA, Taylor WE: Panel Data and Unobservable Individual Effects. Econometrica. 1981, 49 (6): 1377-1398. 10.2307/1911406.View ArticleGoogle Scholar
- Albert K, Sherman B, Backus B: “How length of stay for congestive heart failure patients was reduced through six sigma methodology and physician leadership.,”. Am J Med Qual: J Am Coll Med Qual. 25 (5): 392-397.Google Scholar
- Wick L: Heart Failure Disease Management Improves Outcomes and Reduces Costs. 1998, DuluthGoogle Scholar
- Wright S: Factors influencing the length of hospital stay of patients with heart failure. Eur J Heart Failure. 2003, 5 (2): 201-209. 10.1016/S1388-9842(02)00201-5.View ArticleGoogle Scholar
- Saebu L, Rethans JJ: Management of patients with angina pectoris by GPs: a study with standardized (simulated) patients in actual practice. Family practice. 1997, 14 (6): 431-435. 10.1093/fampra/14.6.431.View ArticlePubMedGoogle Scholar
- Laurenti R, Buchalla CM, De Caratin VS: “Ischemic heart disease. Hospitalization, length of stay and expenses in Brazil from 1993 to 1997,”. Arquivos Brasileiros de Cardiologia. 2000, 74 (6): 488-492.View ArticleGoogle Scholar
- Hausman JA: Specification Tests in Econometrics. Econometrica, Econometric Soc. 1978, 46 (6): 1251-1271. 10.2307/1913827.View ArticleGoogle Scholar
- Cornwell C, Rupert P: Efficient Estimation with Panel Data: An Empirical Comparison of Instrumental Variables Estimators. J Applied Econ. 1988, 3 (2): 149-155. 10.1002/jae.3950030206.View ArticleGoogle Scholar
- The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6963/13/172/prepub
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.